Zhichao Xi

971 total citations · 1 hit paper
35 papers, 574 citations indexed

About

Zhichao Xi is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Zhichao Xi has authored 35 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Zhichao Xi's work include Ubiquitin and proteasome pathways (6 papers), Autophagy in Disease and Therapy (6 papers) and Ginseng Biological Effects and Applications (5 papers). Zhichao Xi is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Autophagy in Disease and Therapy (6 papers) and Ginseng Biological Effects and Applications (5 papers). Zhichao Xi collaborates with scholars based in China, Malaysia and Australia. Zhichao Xi's co-authors include Hong‐Xi Xu, Mengfan Liu, Rongchen Dai, Yang Li, Qihan Dong, Yuanzhi Lao, Hongsheng Tan, Boya Chen, Jiling Feng and Xue Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Zhichao Xi

32 papers receiving 568 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Traditional Chinese medicine in lung cancer treatment

2025 29 citations Zhichao Xi, Rongchen Dai et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhichao Xi China	15	320	123	95	81	72	35	574
Anqi Zeng China	17	435 1.4×	131 1.1×	136 1.4×	92 1.1×	64 0.9×	45	858
Su‐Yu Chien Taiwan	17	341 1.1×	96 0.8×	126 1.3×	63 0.8×	58 0.8×	21	640
Meng‐Liang Lin Taiwan	13	319 1.0×	83 0.7×	98 1.0×	106 1.3×	58 0.8×	27	619
Anusha Bishayee United States	6	388 1.2×	96 0.8×	131 1.4×	62 0.8×	65 0.9×	9	656
SONG-SHEI LIN Taiwan	9	377 1.2×	63 0.5×	89 0.9×	74 0.9×	59 0.8×	10	599
Ankur Karmokar United Kingdom	9	306 1.0×	137 1.1×	76 0.8×	49 0.6×	67 0.9×	15	640
Lubna Therachiyil Qatar	12	345 1.1×	115 0.9×	123 1.3×	41 0.5×	60 0.8×	23	619
Jung Yoon Jang South Korea	15	263 0.8×	86 0.7×	64 0.7×	57 0.7×	139 1.9×	22	571
Hsi‐Hsien Hsu Taiwan	12	309 1.0×	177 1.4×	145 1.5×	53 0.7×	50 0.7×	31	646
Qingdi Quentin Li China	18	393 1.2×	183 1.5×	133 1.4×	44 0.5×	55 0.8×	28	841

Countries citing papers authored by Zhichao Xi

Since Specialization

Citations

This map shows the geographic impact of Zhichao Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhichao Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhichao Xi more than expected).

Fields of papers citing papers by Zhichao Xi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhichao Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhichao Xi. The network helps show where Zhichao Xi may publish in the future.

Co-authorship network of co-authors of Zhichao Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Zhichao Xi. A scholar is included among the top collaborators of Zhichao Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhichao Xi. Zhichao Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xi, Zhichao, et al.. (2025). Traditional Chinese medicine in lung cancer treatment. Molecular Cancer. 24(1). 57–57. 29 indexed citations breakdown →

Xi, Zhichao, Mengfan Liu, Xue Jiang, et al.. (2025). Pterostilbene Induces Apoptosis in Awakening Quiescent Prostate Cancer Cells by Upregulating C/EBP-β-Mediated SOD2 Transcription. International Journal of Biological Sciences. 21(8). 3379–3396.

Ai, Lin, Yuan Wang, Mengfan Liu, et al.. (2025). The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome‐Lysosome Fusion. Cell Proliferation. 59(1). e70071–e70071.

Dai, Rongchen, et al.. (2024). Repurposing cardiac glycosides for anticancer treatment: a review of clinical studies. Drug Discovery Today. 29(10). 104129–104129. 4 indexed citations

Wang, Youyi, Huimin Zheng, Xue Jiang, et al.. (2024). Caged xanthone derivatives to promote mitochondria-mediated apoptosis in breast cancer cells. Bioorganic & Medicinal Chemistry. 103. 117655–117655. 1 indexed citations

Jiang, Xue, et al.. (2024). Unlocking Natural Potential: Antibody‐Drug Conjugates With Naturally Derived Payloads for Cancer Therapy. Phytotherapy Research. 39(2). 789–874. 3 indexed citations

Xi, Zhichao, Lin Ai, Yuan Wang, et al.. (2024). Ginsenoside Rg1 mitigates cerebral ischaemia/reperfusion injury in mice by inhibiting autophagy through activation of mTOR signalling. Acta Pharmacologica Sinica. 45(12). 2474–2486. 9 indexed citations

Wu, Rong, Zhichao Xi, Mengfan Liu, et al.. (2023). Pulsatilla Decoction and its bioactive component β-peltatin induce G2/M cell cycle arrest and apoptosis in pancreatic cancer. Chinese Medicine. 18(1). 61–61. 3 indexed citations

Xi, Zhichao, et al.. (2023). LuQi Formula relieves ventricular remodeling through improvement of HIF-1α-mediated intestinal barrier integrity. Chinese Medicine. 18(1). 90–90. 4 indexed citations

10.

Dai, Rongchen, et al.. (2023). Unveiling the dual role of autophagy in vascular remodelling and its related diseases. Biomedicine & Pharmacotherapy. 168. 115643–115643. 13 indexed citations

11.

Xi, Zhichao, Mengfan Liu, Yang Li, et al.. (2022). Advances in therapeutic agents targeting quiescent cancer cells. SHILAP Revista de lepidopterología. 1(1). 19 indexed citations

12.

Feng, Jiling, Zhichao Xi, Xue Jiang, et al.. (2022). Saikosaponin A enhances Docetaxel efficacy by selectively inducing death of dormant prostate cancer cells through excessive autophagy. Cancer Letters. 554. 216011–216011. 28 indexed citations

13.

Dai, Rongchen, et al.. (2022). OMICS Applications for Medicinal Plants in Gastrointestinal Cancers: Current Advancements and Future Perspectives. Frontiers in Pharmacology. 13. 842203–842203. 7 indexed citations

14.

Xu, Lin, et al.. (2022). Medicinal plants and natural compounds against acyclovir-resistant HSV infections. Frontiers in Microbiology. 13. 1025605–1025605. 5 indexed citations

15.

Dai, Rongchen, et al.. (2022). Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis. Journal of Experimental & Clinical Cancer Research. 41(1). 316–316. 33 indexed citations

16.

Jiang, Xue, Yang Li, Jiling Feng, et al.. (2020). Safrana l Prevents Prostate Cancer Recurrence by Blocking the Re-activation of Quiescent Cancer Cells via Downregulation of S-Phase Kinase-Associated Protein 2. Frontiers in Cell and Developmental Biology. 8. 598620–598620. 21 indexed citations

17.

Bi, Ling, Chanlu Xie, Yao Mu, et al.. (2018). The histone chaperone complex FACT promotes proliferative switch of G₀ cancer cells. International Journal of Cancer. 145(1). 164–178. 23 indexed citations

18.

Li, Yang, Zhichao Xi, Xiaoqiong Chen, et al.. (2018). Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways. Cell Death and Disease. 9(5). 538–538. 39 indexed citations

19.

Xi, Zhichao, Yao Mu, Yang Li, et al.. (2016). Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation. Cell Death and Disease. 7(6). e2252–e2252. 36 indexed citations

20.

Wang, Xiaoyu, Yuanzhi Lao, Naihan Xu, et al.. (2015). Oblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulins. Scientific Reports. 5(1). 10293–10293. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact